Ethanamine compounds and their use for treating depression

Details for Australian Patent Application No. 2012203913 (hide)

Owner AstraZeneca AB

Inventors Balestra, Michael; Bernstein, Peter; Ernst, Glen E.; Frietze, William; McCauley, John P.; Nugiel, David; Shen, Lihong

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012203913

Parent 2009330745

Filing date 4 July 2012

Wipo publication date 26 July 2012

International Classifications

C07D 213/38 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4402 - only substituted in position 2, e.g. pheniramine, bisacodyl

A61P 25/24 Drugs for disorders of the nervous system

Event Publications

19 July 2012 Complete Application Filed

26 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203913

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203914-5imidazoquinolines and pyrimidine derivatives as potent modulators of VEGF-driven angiogenic processes

2012203912-Towing methods and systems for geophysical surveys